Global X Management CO LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Global X Management CO LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$33,000
-31.2%
1,932
-21.1%
0.00%0.0%
Q1 2018$48,000
+29.7%
2,450
+33.4%
0.00%0.0%
Q4 2017$37,000
+48.0%
1,836
+29.2%
0.00%0.0%
Q3 2017$25,000
+56.2%
1,421
+16.8%
0.00%0.0%
Q2 2017$16,000
+220.0%
1,217
+200.5%
0.00%
Q1 2017$5,000
+25.0%
405
+6.6%
0.00%
Q4 2016$4,000
-20.0%
3800.0%0.00%
Q3 2016$5,000
+66.7%
3800.0%0.00%
Q2 2016$3,000
-88.9%
380
-86.3%
0.00%
-100.0%
Q2 2014$27,000
+42.1%
2,779
+83.4%
0.00%
+100.0%
Q1 2014$19,0001,5150.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders